Skip to main content
. 2018 Feb 2;8:2268. doi: 10.1038/s41598-018-20765-8

Figure 4.

Figure 4

The expression level of EMT induction markers. (A) Western blot analysis showing the expression level of S18-2 in PC3, PC3-S18-2-CL03 and PC3-S18-2-CL04. The graph shows the intensity of S18-2 bands, normalized to the intensity of corresponding actin bands. (B) Western blotting showed that E-cadherin and cytokeratin 8 was decreased at the protein levels in PC3-S18-2-CL04 compared with PC3 cells. The expression of β-catenin was not changed among the three cell lines. Actin and Tubulin were used as loading controls, respectively. Scans of all gels are presented in Supplementary Figure S2. (C) The q-PCR analysis of TWIST2. The TWIST2 was expressed at significantly higher levels in PC3-S18-2-CL04 than in the control cells. (D) The TWIST2 mRNA expression after 24 and 48 h of S18-2 downregulation. The TWIST2 gene was downregulated significantly upon S18-2 knocking down by siRNA in PC3 cells. (E) Expression level of S18-2 and CXCR4 in PC3 cells after 24 and 48 h of the treatment of PC3 with S18-2 specific siRNA. As expected, S18-2 was reduced with transfection of S18-2 specific siRNA compared to control siRNA treated cells. CXCR4 was also significantly reduced in cells transfected with S18-2 specific siRNA compared to control siRNA treated PC3 cells. (F) the mRNA expression level of S18-2 and TWIST2 after activation of CXCR4 by CXCL12 treatment. Cells were treated for 24 and 48 h. The TWIST2 gene was induced after 48 h. The S18-2 expression was not affected by CXCL12 treatment. All the experiments were repeated at least three times. Medians of three q-PCR reactions were analyzed, using the GraphPad Prism software. Unpaired t test was applied and two tailed p values for each experiment (controls −3, 24 h −3, 48 h −3 values) were determined.